References
- BanghamADHorneRWNegative staining of phospholipids and their structured modofication by surface active agents as observed in the electron microscopeJ Mol Biol1964866066814187392
- BlackCDWatsonGJWardRJThe use of Pentostam liposomes in the chemotherapy of experimental leishmaniasisTrans R Soc Trop Med Hyg197771550552204085
- IyerAKKhaledGFangJMaedaHExploiting the enhanced permeability and retention effect for tumor targetingDrug Discov Today20061181281816935749
- LehtinenJMagarkarAStepniewskiMAnalysis of cause of failure of new targeting peptide in PEGylated liposome: molecular modeling as rational design tool for nanomedicineEur J Pharm Sci20124612113022381076
- CevcGSchätzleinAGebauerDBlumeGUltra-high efficiency of drug and peptide transfer through the intact skin by means of novel drug-carriers, TransfersomesBainKRHadgkraftJJamesWJWaterKAPrediction of Percutaneous Penetration3bCardiffSTS Publishing1993226234
- CevcGRational design of new product candidates: the next generation of highly deformable bilayer vesicles for noninvasive, targeted therapyJ Control Release201216013514622266051
- KumarAPathakKBaliVUltra-adaptable nanovesicular systems: a carrier for systemic delivery of therapeutic agentsDrug Discov Today2012171233124122766375
- CevcGVierlUinventorsIdea Ag, assignee. NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery United Sates patent US 7473432 B2200916
- CevcGVierlUinventorsIdea Ag, assignee. Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin United Sates patent US 20090155235 A12009618
- ElsayedMMCevcGThe vesicle-to-micelle transformation of phospholipid– cholate mixed aggregates: a state of the art analysis including membrane curvature effectsBiochim Biophys Acta2011180814015320832388
- CevcGMaterial transport across permeability barriers by means of lipid vesiclesLipowskyRSackmannEHandbook of Biological PhysicsIElsevier Science B.V1995465489
- CevcGVierlUNanotechnology and the transdermal route. A state of the art review and critical appraisalJ Control Release201014127729919850095
- BonchevaMde SterkeJCaspersPJPuppelsGJDepth profiling of stratum corneum hydration in vivo: a comparison between conductance and confocal Raman spectroscopic measurementsExp Dermatol20091887087619469890
- WarnerRRLillyNACorrelation of Water Content with Ultrastructure in the Stratum CorneumFriedrich-SchillerPEBerardescaEMaibachHIBioengineering of the Skin. Water and the Stratum Corneum, Volume I. Dermatology: Clinical & Basic Science Part No. 6Boca Raton, FLInforma Healthcare1994312
- CevcGBlumeGLipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration forceBiochim Biophys Acta199211042262321550849
- CevcGGebauerDHydration-Driven transport of deformable lipid vesicles through fine pores and the skin barrierBiophys J2003841010102412547782
- CevcGBlumeGSchtitzleinAGebauerDPaulAThe skin: a pathway for systemic treatment with patches and lipid-based agent carriersAdv Drug Del Rev1996183349378
- SchreierHBouwstraJLiposomes and niosomes as topical drug carriers: dermal and transdermal drug deliveryJ Control Release1994301115
- MitragotriSModeling skin permeability to hydrophilic and hydrophobic solutes based on four permeation pathwaysJ Control Release200386699212490374
- MitragotriSA theoretical analysis of permeation of small hydrophobic solutes across the stratumcorneumbased on scaled particle theoryJ Pharm Sci20029174475211920759
- SchätzleinACevcGNon-uniform cellular packing of the stratum corneum and permeability barrier function of intact skin: a high-resolution confocal laser scanning microscopy study using highly deformable vesicles (Transfersomes)Br J Dermatol19981385835929640361
- CevcGSchätzleinARichardsenHUltradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurementsBiochim Biophys Acta20021564213012100992
- CevcGInventorCevcGassigneeOptimised preparations of highly adaptable aggregates PCT/EP2012/0550402012927
- CevcGInventorCevcGassigneeDrug-free compositions and methods for diminishing peripheral inflammation and pain PCT/EP2012/0550392012927
- van den BerghBAIVroomJGerritsenHJungingerHEBouwstraJAInteractions of elastic and rigid vesicles with human skin in vitro: electron microscopy and two- photon excitation microscopyBiochim Biophys Acta1999146115517310556497
- Honeywell-NguyenPLde GraaffAJungingerHEWouter GroeninkHWBouwstraJAThe in vivo and in vitro interactions of elastic and rigid vesicles with human skinBBActa20021573130140
- Honeywell-NguyenPLBouwstra JokeAThe in vitro transport of pergolide from surfactant-based elastic vesicles through human skin: a suggested mechanism of actionJ Control Release20038614515612490380
- TouitouEInventorCompositions for applying active substances to or through the skin United Sates patent 5,540,9341996730
- TouitouEInventorYissum Research Development Company of The Hebrew University of Jerusalem, Jerusalem, Israel assignee. Composition for applying active substances to or through the skin United Sates patent 5,716,6381998210
- ChinJMGoldsteinDBMembrane disordering action of ethanol: variation with membrane cholesterol content and depth of the spin label probeMol Pharmacol19811934254317266465
- HarrisRABurnettRMcQuiilkinSMcCloudASimonFREffect of ethanol on membrane order: fluorescence studiesAnn N Y Acad Sci19874921251353474923
- ZhangZWoYZhangYIn vitro study of ethosome penetration in human skin and hypertrophic scar tissueNanomedicine201281026103322033085
- TouitouEGodinBWeissCEnhanced delivery of drugs into and across the skin by ethosomal carriersDrug Dev Res200050406415
- TouitouEDayanNBergelsonLGodinBEliazMEthosomes – novel vesicular carriers for enhanced delivery: characterization and skin penetration propertiesJ Control Rel200065403418
- BlumeAJansenMGhyczyMGareisJInteraction of phospholipid liposomes with lipid model mixtures for stratum corneum lipidsInt J Pharm199399219228
- Van der MerweDRiviereJEComparative studies on the effects of water, ethanol and water/ethanol mixtures on chemical partitioning into porcine stratum corneum and silastic membraneToxicol In Vitro200519697715582358
- CevcGLipid vesicles and other colloids as drug carriers on the skinAdv Drug Del Rev200456675711
- CevcGMazgareanuSRotherMPreclinical characterisation of NSAIDs in ultradeformable carriers or conventional topical gelsInt J Pharm2008360293918337027
- CevcGMazgareanuSRotherMVierlUOcclusion effect on transcutaneous NSAID delivery from conventional and carrier-based formulationsInt J Pharm200835919019718499370
- BahiaAPAzevedoEGFerreiraLAMFrézardFNew insights into the mode of action of ultradeformable vesicles using calcein as hydrophilic fluorescent markerEur J Pharm Sci201039909619903526
- ElsayedMMAbdallahOYNaggarVFKhalafallahNMDeformable liposomes and ethosomes: mechanism of enhanced skin deliveryInt J Pharm2006322606616806755
- VermaDDInvasomes-Novel Topical Carriers for Enhanced Topical Delivery: Characterization and Skin Penetration Properties [PhD thesis]Marburg/Lahn2002
- VermaDDVermaSMcElweeKJFreyschmidt-PaulPFahrATreatment of alopecia areata in the DEBR model using cyclosporin A lipid vesiclesEur J Dermatol20041433233815358573
- NtimenouVFahrAAntimisiarisSGElastic vesicles for transdermal drug delivery of hydrophilic drugs: a comparison of important physicochemical characteristics of different vesicle typesJ Biomed Nanotechnol2012861362322852471
- ManconiMMuraSSinicoCFaddaAMVilaAOMolinaFDevelopment and characterization of liposomes containing glycols as carriers for diclofenacColloids and Surfaces A: Physicochem. Eng Aspects20093425358
- ManconiMCaddeoCSinicoCEx vivo skin delivery of diclofenac by transcutol containing liposomes and suggested mechanism of vesicle-skin interactionEur J Pharm Biopharm201178273521167279
- TrakatelliMUlrichCdel MarmolVEuvrardSStockflethEAbeniDEpidemiology of nonmelanoma skin cancer (NMSC) in Europe: accurate and comparable data are needed for effective public health monitoring and interventionsBr J Dermatol2007156Suppl 31717488399
- KimRHArmstrongAWNonmelanoma skin cancerDermatol Clin20123012513922117874
- RogersHWWeinstockMAHarrisARIncidence estimate of nonmelanoma skin cancer in the United States, 2006Arch Dermatol201014628328720231499
- ChengKWMattheolabakisGWongCCTopical phospho-sulindac (OXT-328) is effective in the treatment of non-melanoma skin cancerInt J Oncol2012411199120322842609
- LauKGHattoriYChopraSUltra-deformable liposomes containing bleomycin: in vitro stability and toxicity on human cutaneous keratinocyte cell linesInt J Pharm200530041215946810
- HirutaYHattoriYKawanoKObataYMaitaniYNovel ultra-deformable vesicles entrapped with bleomycin and enhanced to penetrate rat skinJ Control Release200611314615416793162
- QiuYGaoYHuKLiFEnhancement of skin permeation of docetaxel: a novel approach combining microneedle and elastic liposomesJ Control Release200812914415018538885
- PaolinoDCeliaCTrapassoECilurzoFFrestaMPaclitaxel-loaded ethosomes®: potential treatment of squamous cell carcinoma, a malignant transformation of actinic keratosesEur J Pharm Biopharm20128110211222414731
- HosmerJMShinSHNornooAZhengHLopesLBInfluence of internal structure and composition of liquid crystalline phases on topical delivery of paclitaxelJ Pharm Sci201110014441455
- PanchagnulaRDesuHJainAKhandavilliSEffect of lipid bilayer alteration on transdermal delivery of a high-molecular-weight and lipophilic drug: studies with paclitaxelJ Pharm Sci2004932177218315295779
- CrosassoPCerutiMBrusaPArpiccoSDosioFCattelLPreparation, characterization and properties of sterically stabilized paclitaxel-containing liposomesJ Control Release200063193010640577
- FangJYTsaiY-HWuP-CHuangYBComparison of 5-aminolevulinic acid-encapsulated liposome versus ethosome for skin delivery for photodynamic therapyInt J Pharm200835614415218325699
- De RosaFSBentleyMVPhotodynamic therapy of skin cancers: sensitizers, clinical studies and future directivesPharm Res2000171447145511303952
- HendersonBWDoughertyTJHow does photodynamic therapy work?Photochem Photobiol1992551451571603846
- SzeimiesRMMortonCASidoroffABraathenLRPhotodynamic therapy for non-melanoma skin cancerActa Derm Venereol20058548349016396794
- PengQWarloeTBergK5-Aminolevulinic acid-based photodynamic therapyCancer199779228223089191516
- YatvinMBLelkesPIClinical prospects for liposomesMed Phys198291491757045623
- BarryBWNovel mechanisms and devices to enable successful transdermal drug deliveryEur J Pharm Sci20011410111411500256
- FangJYHwangTLHuangYLLiposomes as vehicles for enhancing drug delivery via skin routesCurr Nanosci200625570
- Dragicevic-CuricNScheglmannDAlbrechtVFahrATemoporfin-loaded invasomes: development, characterization and in vitro skin penetration studiesJ Control Release2008127596918281119
- Dragicevic-CuricNGrafeSAlbrechtVFahrATopical application of temoporfin-loaded invasomes for photodynamic therapy of subcutaneously implanted tumours in mice: a pilot studyJ Photochem Photobiol B200891415018316200
- Dragicevic-CuricNScheglmannDAlbrechtVFahrADevelopment of different temoporfin-loaded invasomes – novel nanocarriers of temoporfin: characterization, stability and in vitro skin penetration studiesColloids Surf B Biointerfaces20097019820619188048
- Dragicevic-CuricNGräfeSGitterBFahrAEfficacy of temoporfin-loaded invasomes in the photodynamic therapy in human epidermoid and colorectal tumour cell linesJ Photochem Photobiol B201010123825020797872
- Dragicevic-CuricNGrafeSGitterBWinterSFahrASurface charged temoporfin-loaded flexible vesicles: in vitro skin penetration studies and stabilityInt J Pharm201038410010819819321
- CevcGBlumeGSchatzleinATransfersomes-mediated transepidermal delivery improves the regio- specificity and biological activity of corticosteroids in vivoJ Control Release199745211226
- CevcGBlumeGBiological activity and characteristics of triamcinolone-acetonide formulated with the self-regulating drug carriers, TransfersomesBiochim Biophys Acta2003161415616412896808
- CevcGBlumeGHydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosageBiochim Biophys Acta20041663617315157608
- DavisAFHadgraftJEffect of supersaturation on membrane transport: 1. Hydrocortisone acetateInt J Pharm19917618
- LiapiCChrousosGPGlucocorticoidsJaffeSJArandaJVPediatric Pharmacology Therapeutic Principles in Practice2nd edPhiladelphiaSaunders1992466475
- WarnerRRMyersMCTaylorDTElectron probe analysis of human skin determination of the water concentration profileJ Invest Dermatol1988902182243339263
- FesqHGlöcknerDAbeckDImproved risk-benefit ratio for a triamcinolone acetonide TransfersomeR formulation in comparison to a commercial triamcinolone acetonide formulationBr J Dermatol200314961161914510997
- ReynoldsJIFThe Extra Pharmacopoeia (Martindale)LondonThe Pharmaceutical Press1993620637
- LodzkiaMGodinaBRakouaLMechoulambRGallilycRTouitouECannabidiol – transdermal delivery and anti-inflammatory effect in a murine modelJ Control Release20039337738714644587
- PaolinoDLucaniaGMardenteDAlhaiqueFFrestaMIn vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteersJ Control Release20051069911015935505
- SimoesSIDelgadoTCLopesRMDevelopments in the rat adjuvant arthritis model and its use in therapeutic evaluation of novel non-invasive treatment by SOD in TransfersomesJ Control Release200510341943415763624
- CevcGBlumeGNew, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, TransfersomesBiochim Biophys Acta2001151419120511557020
- ToddPASorkinEMDiclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacyDrugs1988352442853286213
- SinghPRobertsMSSkin permeability and local tissue concentrations of non-steroidal anti-in£ammatory drugs after topical applicationJ Pharmacol Exp Ther19942681441518301551
- HadgraftJde PlessisJGoosenCThe selection of non-steroidal anti-inflammatory agents for dermal deliveryInt J Pharm2000207313711036227
- MitragotriSJohnsonMEBlankschteinDLangerRAn analysis of the size selectivity of solute partitioning, diffusion, and permeation across lipid bilayersBiophys J1999771268128310465741
- BravermanIMThe cutaneous microcirculation: ultrastructure and microanatomical organizationMicrocirculation199743293409329009
- Monteiro-RiviereNAInmanAORiviereJEMcNeilSCTopical penetration of piroxicam is dependent on the distribution of the local cutaneous vasculaturePharm Res199310132613318234171
- CevcGVierlUMazgareanuSFunctional characterisation of novel analgesic product based on self-regulating drug carriersInt J Pharm2008360182818524509
- CaddeoCDiez SalesOValentiaDRuiz SauríAFaddaAMManconiMInhibition of skin inflammation in mice by diclofenac in vesicular carriers: liposomes, ethosomes and PEVsInt J Pharm201344312813623299087
- CevcGVierlUInventorsIdea Ag, assignee. Aggregates with increased deformability, comprising at least three amphiphats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin European Patent EP1551370 A12005713
- RotherMCevcGIDEA updates on Diractin® (ketoprofen in Transfersome® gel) statusMunichIDEA AG2009 Available from: http://www.technostart.com/down/r_d_2_091007_PR_Diractin.pdf32013
- ChourasiaMKKangLChanSYNanosized ethosomes bearing ketoprofen for improved transdermal deliveryResults Pharma Sci201116067
- KuniiTHiraoTKikuchKTagamiHStratum corneum lipid profile and maturation pattern of corneocytes in the outermost layer of fresh scars: the presence of immature corneocytes plays a much more important role in the barrier dysfunction than do changes in intercellular lipidsBr J Dermatol200314974975614616365
- SogabeYAkimotoSAbeMIshikawaOTakagiYImokawaGFunctions of the stratum corneum in systemic sclerosis as distinct from hypertrophic scar and keloid functionsJ Dermatol Sci200229495312007721
- ZuradaJMKriegelDDavisICTopical treatments for hypertrophic scarsAm Acad Dermatol20065510241031
- ChungVKelleyLMarraDJiangSBOnion extract gel versus petrolatum emollient on new surgical scars: prospective double-blinded studyDermatol Surg20063219319816442038
- HeRCuiD-XGaoFPreparation of fluorescence ethosomes based on quantum dots and their skin scar penetration propertiesMater Lett20096316621664
- HatamipourEMehrabiSHatamipourMGhafarian ShiraziHREffects of combined intralesional 5-fluorouracil and topical silicone in prevention of keloids: a double blind randomized clinical trial studyActa Med Iran20114912713021681697
- MaoXHWoYHeRQianYLZhangYXCuiDXPreparation and characterization of different sizes of ethosomes encapsulated with 5-fluorouracil and its experimental study of permeability in hypertrophic scarJ Nanosci Nanotechnol2010104178418321128398
- LowesMABowcockAMKruegerJGPathogenesis and therapy of psoriasisNature200744586687317314973
- WitmanPMTopical therapies for localized psoriasisMayo Clin Proc20017694394911560307
- SchönMPBoehnckeWHPsoriasisN Engl J Med2005181899191215872205
- GottliebABPsoriasis: emerging therapeutic strategiesNat Rev Drug Discov20054193415688070
- KleinABabilasPKarrerSLandthalerMSzeimiesRMPhotodynamic therapy in dermatology – an updateJ Dtsch Dermatol Ges2008683984518400022
- FangY- PHuangY-BWuaP-CTsaiY-HTopical delivery of 5-aminolevulinic acid-encapsulated ethosomes in a hyperproliferative skin animal model using the CLSM technique to evaluate the penetration behaviorEur J Pharm Biopharm20097339139819660544
- GodinBTouitouETransdermal skin delivery: predictions for humans from in vivo, ex vivo and animal modelsAdv Drug Deliv Rev20071152116117889400
- TanakaYPathogenesis and guidelines for therapy of atopic dermatitisNihon Rinsho2001591219122711411139
- WahlgrenCFPathophysiology of itching in urticaria and atopic dermatitisAllergy19924765751632481
- LeungDYBieberTAtopic dermatitisLancet200336115116012531593
- WatanabeMTagamiHHoriiITakahashiMKligmanAMFunctional analyses of the superficial stratum corneum in atopic xerosisArch Dermatol1991127168916921952974
- BarnetsonRSWhiteADThe use of corticosteroids in dermatological practiceMed J Aus1992156428431
- LeungAKBarberKAManaging childhood atopic dermatitisAdv Ther20032012913712956254
- LeeOChoiMHaSEffect of pedunculagin investigated by non-invasive evaluation on atopic-like dermatitis in NC/Nga miceSkin Res Technol20101637137720637007
- KangMJEumJYParkSHPep-1 peptide-conjugated elastic liposomal formulation of taxifolin glycoside for the treatment of atopic dermatitis in NC/Nga miceInt J Pharm201040219820420888893
- KimYJChoiSELeeMWLeeCSTaxifolin glycoside inhibits dendritic cell responses stimulated by lipopolysaccharide and lipoteichoic acidJ Pham Pharmacol20086014651472
- HouYWChanMHHsuHRTransdermal delivery of proteins mediated by non-covalently associated arginine-rich intracellular delivery peptidesExp Dermatol200716999100618031459
- LopesLBBrophyCMFurnishEComparative study of the skin penetration of protein transduction domains and a conjugated peptidePharm Res20052275075715906170
- KangMJKimBGEumJYDesign of a Pep-1 peptide- modified liposomal nanocarrier system for intracellular drug delivery: conformational characterization and cellular uptake evaluationJ Drug Target20111949750520738150
- LiGFanYFanCTacrolimus-loaded ethosomes: physicochemical characterization and in vivo evaluationEur J Pharm Biopharm201282495722705640
- BieberTTopical tacrolimus (FK 506): a new milestone in the management of atopic dermatitisJ Allergy Clin Immunol19981025555579802361
- NakagawaHEtohTIshibashiYTacrolimus ointment for atopic dermatitisLancet19943448837522297
- InagakiNShiraishiNIgetaKInhibition of scratching behavior associated with allergic dermatitis in mice by tacrolimus, but not by dexamethasoneEur J Pharmacol200654618919616914137
- WilliamsACTransdermal and Topical Drug Delivery; from theory to clinical practiceLondonPharmaceutical Press2003
- JacobsMDHarrisonSCStructure of an IkappaBalpha/NF-kappaB complexCell1998957497589865693